© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Ethopabate entered the scene back in the late 1950s when scientists ramped up the search for effective feed additives to protect poultry from the scourge of coccidiosis. This was a time when the poultry industry grew by leaps and bounds, and losses from protozoan parasites were a real blow to farmers’ livelihoods. Ethopabate quickly earned attention because it offered reliable control without sacrificing growth rates or egg production. Early studies, mostly in labs across Europe and North America, pointed towards ethopabate’s ability to shut down the folic acid synthesis that coccidia needed to develop. As producers watched profits swing on disease prevention, chemists and veterinarians started to see ethopabate products as indispensable, not just another option on a crowded shelf.
Looking at feed additives today, ethopabate stands out as a product engineered for animal health. On its own, you’ll find ethopabate sold as a powder, but more often it’s mixed into premixes or feed formulations aimed at coccidiosis control in broilers, turkeys, and occasionally rabbits. What always grabs attention is that it usually appears in combination with other coccidiostats—using synergy to keep resistance at bay. You don’t see ethopabate touted like a miracle, but it underpins feed strategies in plenty of countries where the disease refuses to loosen its grip. Trademarked names might change from region to region, but the substance keeps the main features that built its reputation: steady performance and a track record in both high-volume production and small, rural flocks.
Pure ethopabate draws a picture of pale-yellow powder, odorless and rarely presenting handling difficulties. On a bench, it demonstrates a melting point of 146-148°C, reassuring those used to dealing with substances that break down under heat. Speaking as someone who’s worked with chemicals in less-than-ideal storage conditions, ethopabate behaves well, staying stable for months if you keep it dry and away from intense light. Solubility is a practical point—ethopabate dissolves with effort in organic solvents like methanol and acetone, but refuses water. This lack of water solubility fits the bill in feed applications since it avoids leaching during pelleting or storage. The molecular formula—C14H15NO4—means it packs a good deal of activity in a small footprint, and one glance at the compound’s structure hints at its targeted biological action.
Regulators across the world make sure ethopabate doesn’t fly under the radar. Labeling standards remain clear, right down to purity specifications that hover above 98%, maximum allowable heavy metal content, and precise methods for quantifying active ingredient. The typical recommended inclusion rate stays within 0.0125% to 0.025% in finished feed, and labels break down not just the concentration but also warnings about withdrawal periods before slaughter, aiming to keep residues out of the food chain. From direct experience in the industry, farmers read these withdrawal times carefully—that’s the difference between compliance and censure. Country-to-country variations can spark confusion, but well-prepared guidance sheets allow producers to navigate the requirements, ensuring transparency from mill to farm gate.
Making ethopabate doesn’t take an exotic toolkit, but it does demand careful process control. The classic synthesis involves condensing 4-acetamidobenzoic acid with ethyl 4-chloroacetoacetate, using a basic catalyst to steer the reaction towards the ethyl 4-acetamidobenzoate intermediate. After a controlled hydrolysis and careful isolation, chemists complete the sequence by forming and purifying the end product through recrystallization. Small deviations in temperature or impurity management shift yields and purity levels, making process tweaks a daily topic in manufacturing labs. Manufacturers invest in batch testing, keeping each lot up to the official mark—and those who skip the quality checks soon find markets closed to their product.
Ethopabate’s chemistry allows moderate flexibility for downstream modifications. It can take part in hydrolysis, either stripping away the ethyl ester or breaking the acetamide link to give other benzoic acid derivatives. These changes might alter uptake or biological activity, and some labs keep a close watch for new analogues that might offer stronger or broader activity against different Eimeria species. While some chemical cousins have crept into field trials, none have dislodged ethopabate’s place—mainly because they don’t improve upon the delicate balance of activity and safety the original offers. From my point of view, scientists will keep tweaking the scaffold, but any real replacement has to do much more than change a functional group.
Around the globe, you might hear ethopabate under other names, depending on local regulations and branding traditions. ‘Ethopabate’ is its INN, though feed formulators in some markets still refer to it as 4-Acetamido-2-ethoxybenzoic acid, which traces straight back to its structure. Commercial names in the EU and Asia usually put the spotlight on either the chemical backbone or a farm-friendly term that signals disease control. In veterinary handbooks, synonyms like Cevabene and Ethobane crop up, but professionals rely on the fine print—CAS number 59-06-3—to remove all doubt about which molecule sits inside the bag.
Handling ethopabate in feed mills, research settings, or farm storage rooms means treating it with respect. While it doesn’t carry the acute toxicity risk of many coccidiostats used in the past, the usual safety measures make sense: gloves, dust masks, well-ventilated mixing areas. Chronic exposure—breathing in dust day after day or handling large volumes without breaks—can sometimes irritate skin and mucous membranes. Regulatory bodies list ethopabate as relatively safe to work with, but demand strict adherence to feed labeling, avoidance of cross-contamination, and regular residue checks. Safety audits now form part of any major feed operation, and farmers keep a wary eye on storage conditions since trace contamination can trigger whole-batch recalls. For animal safety, studies have established maximum residue levels (MRLs) in line with strict food laws, preventing drug build-up in meat and eggs.
The biggest footprint for ethopabate sits squarely in poultry farming. Broilers, layers, breeding flocks—producers rely on coccidiostat feed premixes because skipping disease prevention usually ends in financial ruin. In parts of the world where coccidiosis runs rampant, substituting ethopabate with less-proven options can double mortality rates and gut damage. Aside from poultry, some commercial rabbit operations benefit from its inclusion against Eimeria species too. Use isn’t restricted to big integrators—this is one of those medicines with relevance on smallholdings, backyard flocks, and export-driven enterprises alike. Since resistance remains a looming threat, professional nutritionists rotate ethopabate with other actives, tailoring programs based on challenge levels, season, and animal stress. Feed suppliers keep careful inventories to make sure combination products always contain accurate ethopabate levels, a safeguard that stops dosing slips.
Researchers keep exploring ways to stretch ethopabate’s value or work around its limitations. Current projects center on measuring field resistance in Eimeria strains, hunting for ways to protect the molecule’s activity for longer and side-stepping overuse. Some labs benchmark ethopabate’s performance against natural products, probiotics, and new-generation antimicrobials, testing every angle for disease control that might introduce fewer drug residues or shorter withdrawal times. Data from university trials and multinational feed companies typically feed into published meta-analyses that policymakers reference when reviewing registration or reviewing permitted combinations. The ongoing search for metabolic markers could unlock new residue tracking systems, adding another check for food safety. Developers also keep sifting through possible uses outside poultry—expanding the playing field as animal protein consumption climbs worldwide and disease threats grow more complex.
Solid data backs the assessment that ethopabate’s toxicity profile gives it a big advantage over more aggressive coccidiostats of past decades. Acute oral toxicity in lab animals sits at a level far above practical usage, and studies on target species confirm a wide margin between effective and harmful doses—though, as with all veterinary medicines, errors in inclusion can still spell trouble. The main concern for both animals and end consumers hinges on residue carryover, so pharmacokinetic studies keep detailing how quickly ethopabate and its byproducts clear out of tissue. Regulation demands careful analysis for genotoxicity, carcinogenicity, and potential for chronic effects, and the molecule’s record has stood up to these questions. A few cases of cross-sensitivity pop up now and then, mainly in species that aren’t primary targets, so specialists urge caution with off-label use. Clear feed mixing instructions and withdrawal periods help avoid unpleasant surprises, locking in both animal safety and public trust.
Looking ahead, ethopabate’s position faces both opportunity and challenge. Global protein demand keeps climbing, so long as consumers keep eating more chicken and eggs, the fight against coccidiosis will not let up. Feed additive innovation promises alternatives, but for the foreseeable future, ethopabate’s legacy of predictable, affordable disease control still matters—especially for emerging markets where newer drugs prove cost-prohibitive or struggle with distribution. To carve out a long-term role, manufacturers and regulators need to double down on resistance monitoring and international residue harmonization. One sees some promise in pairing ethopabate with advanced diagnostics and vaccine programs, a blend where old and new work together. If industry cooperates to prevent overreliance and heed lessons offered by resistance trends, ethopabate could remain a go-to solution for both conventional and progressive farming systems. Experience says that, just as older tools get retired when new ones do better, ethopabate will stick around as long as it keeps protecting livestock, delivering safe food, and supporting rural economies.
Coccidiosis tears through flocks of chickens with little warning, leaving farmers counting their losses. Most poultry owners have faced it at some point—the sudden weight loss, dull feathers, droopy posture, and, worst of all, deaths in young birds. Parasites known as Eimeria sneak in, attacking the gut, robbing birds of energy, and costing farmers dearly in lost production. Ethopabate steps in as one of the tools designed to fight this parasite.
Ethopabate makes its mark as an anticoccidial drug, usually added to poultry feed in small, carefully measured doses. After decades of use, it's become clear that it acts on a narrow range of parasites, especially Eimeria tenella and Eimeria acervulina, which cause some of the worst forms of the disease in chickens. My own background in poultry farming showed time and again how the right medication in the feed stifles an outbreak, keeping the birds lively and growing. Many veterinary sources confirm its value; for instance, a study in the journal Poultry Science found that birds receiving additives like ethopabate saved a flock from a 30% drop in feed intake following coccidiosis.
On any commercial farm, one sick bird often signals trouble for hundreds more. Fast-acting measures matter—and that usually means medicated feed. Ethopabate delivers results for specific Eimeria strains where other drugs sometimes fall short. It’s not the only anticoccidial product, but it earns a place on the shelf due to its focused activity and comparatively low risk of resistance, especially when rotated with other drugs. Monitoring by authorities keeps residues in poultry products well below the levels considered safe by the World Health Organization, calming any fears about food safety.
Experience says overuse of any medication can create bigger problems, and ethopabate is no different. Some Eimeria species build resistance if the same drug appears in feed month after month. Experts warn about the risk of relying only on pharmaceutical defenses. Farmers who switch up medications, use integrated management practices, and watch for early warning signs of coccidiosis tend to sidestep drug resistance and keep flocks healthier over time. Consumer demands for residue-free meat also argue for proper timing and responsible withdrawal periods before slaughter.
Disease control never comes down to just one product. Efforts like cleaning barns thoroughly, reducing overcrowding, providing dry bedding, and offering healthy diets can go a long way. Vaccines against certain Eimeria strains offer another alternative, though these still need skillful application. Ethopabate remains an important tool, judged by its ability to help farmers minimize losses without overwhelming the food chain with chemicals. As a farmer, veterinarian, or consumer, focusing on balanced, evidence-based approaches tends to win the biggest reward: safe, plentiful chicken and peace of mind at the dinner table.
Ethopabate plays a pretty crucial role in controlling coccidiosis in poultry. Anyone who has spent time raising chickens or dealing with poultry health issues knows coccidiosis can sweep through a flock and cause serious headaches for both the birds and the farmers. Birds that show signs like bloody droppings or poor growth usually signal trouble, and finding solutions fast matters. Ethopabate offers such a solution – but only if used in the right dose.
The recommended dose for Ethopabate in feed sits at about 0.5 parts per million, or 0.00005% by weight of feed. That's not a random number. Decades of research from veterinarians and animal scientists have settled on this level because it stops the protozoa from multiplying without clogging up the kidneys or stunting growth. Go above the recommended amount, and residues may end up in eggs or meat. Dip below, and coccidiosis might not budge, giving the parasites a fighting chance.
Countries with strict food safety rules, like the United States, the UK, and Australia, set firm guidelines for drugs in animal production. The approved label and materials from respected organizations such as the World Health Organization (WHO) and Food and Agriculture Organization (FAO) back up this 0.5 ppm dosing. In my own work raising backyard chickens, I always check country-specific guidance, since some areas limit or ban certain coccidiostats depending on the production system. It surprises people how easy it is to accidentally get dosing wrong if you eyeball the powder and mix by hand. Investing in a good scale keeps errors to a minimum.
Some folks think doubling up will get birds back on their feet quicker. That’s a risky move, especially for flocks whose feed consumption isn’t steady or for smaller birds that eat less. Problems like reduced feed intake, feather loss, and slower weight gain tend to show up in those flocks. In rare cases, high doses can even lead to toxicity. I’ve seen inexperienced keepers panic after a coccidiosis outbreak and flood their feed with medication, only to deal with a harder mess later.
A better route involves sticking to the official label instructions and keeping records. Feed manufacturers usually include pulse-medication programs in their schedules, which rotate in and out drugs like Ethopabate to keep resistance from building up. Farmers can work with veterinarians to spot-check birds and monitor for signs of both disease and medicine overuse.
Anticoccidial resistance is on the rise. Using any coccidiostat without planning can leave us with fewer tools down the road. I have read accounts from commercial producers who lost whole flocks after years of overusing one product. Integrating management practices like regular litter changes, dry bedding, and moving portable pens helps reduce coccidiosis pressure. Layering these with properly dosed Ethopabate keeps medication as a backup tool – not the only line of defense.
For poultry keepers, trust the data and label directions. Ethopabate works at around 0.5 ppm in feed, and that’s where performance peaks without putting bird health or food safety at risk. A careful balance, quality feed mixing, and good record-keeping protect both the flock and the families relying on their eggs or meat.
Ethopabate turns up in some pretty crucial places—most commonly in poultry farming, as a coccidiostat to keep parasites at bay. Anyone who has spent time on a farm knows just how devastating coccidiosis can be for a flock. Birds slow down, health sags, productivity drops, and losses turn serious. Farmers reached for ethopabate decades ago because it offered a path out of this loss spiral.
Now, as with anything that goes into the feed, questions about side effects don't take long to follow. From experience growing up around livestock, it’s clear that talk on animal medications travels fast. I remember older farmers raising eyebrows at names they couldn’t pronounce and demanding straight answers. They wanted facts, not just technical reassurances.
The reports on ethopabate in poultry have shown some patterns. If you give too much, birds may eat less and lose weight. That’s not something producers can ignore, since lower feed intake always hits hard on the bottom line. In some studies, young chicks being fed higher doses showed slower growth. Intestinal lining irritation sometimes gets mentioned as well—hard to notice if you’re just glancing at the birds, but a vet or lab can pick it up.
Allergic reactions in workers handling ethopabate aren’t off the table. I know a few hands who broke out in rashes after mixing feed, so gloves and respirators became standard fare. It’s not about causing fear; it’s about knowing that skin or respiratory trouble could show up with enough contact or carelessness during handling.
It’s also worth remembering that like many substances designed to target parasites, withdrawal periods matter. Feeding any flock medication past the recommended period runs the risk of residues ending up in eggs or meat—and this turns into a consumer trust issue. European agencies and the US FDA set strict residue limits for this reason. If residues exceed safety limits, the whole batch faces rejection or fines, something no producer wants to see.
Part of stewardship in animal agriculture includes keeping tabs on potential risks. If birds go off their feed or show slower weight gain, you notice quickly. But a large operator might only spot these side effects through careful record-keeping, regular vet input, and watching performance numbers over time.
This discussion also hits home because of antibiotic and drug resistance. Using ethopabate or any other coccidiostat carelessly can drive resistance, making the drug less useful over time. I’ve listened to experts at extension meetings warn against over-reliance on any single compound. Rotating drugs, monitoring coccidia loads, and keeping the barns clean form the backbone of responsible management.
Relying on the same medication season after season will make problems crop up. Smart producers work with nutritionists and veterinarians to choose the right dose and rotate products. Feed mills play a part by keeping a close eye on mixing processes so that every batch stays within safe margins.
Using personal protective equipment stands as a straightforward solution for those mixing high volumes of medicated feed—gloves, masks, and careful storage routines have kept plenty of handlers healthy. On the regulatory side, strict recordkeeping of withdrawal periods ensures that food reaching consumers meets national standards.
All told, vigilance and transparency, not shortcuts, form the basis for getting the benefits of ethopabate without the baggage of unnecessary side effects. Honest conversations on medication use—across farms, labs, and regulatory offices—do more to protect animal and human health than any paperwork ever could.
Ethopabate stands out as a staple in poultry health, protecting livestock from coccidiosis. A bag left open on a shelf, or a container sitting near a sunlit window, can quickly turn a good treatment into a risk. Spoiled or degraded ethopabate puts flocks and, by extension, entire operations in danger. Years of watching folks handle farm chemicals teaches one thing: attention to detail with storage saves headaches and money later.
Exposure to heat and moisture breaks down ethopabate faster than many expect. Chemicals, especially ones in powder or crystal form, attract water from the air, clump together, and lose their punch. Opening a box to find a caked-together block that refuses to mix evenly does not inspire much confidence. Contamination sneaks in too easily with poor habits—farm dust, bits of spilled feed, and other chemicals can all turn an expensive investment into a messy liability.
Keep ethopabate in a cool, dry spot away from the busiest parts of the barn or storehouse. I have always relied on steel or high-grade plastic containers; they shut tight, keep out pests, and survive rough handling. A locked cabinet works best, especially with young helpers or visitors on the property. Try to put the supply where direct sunlight never reaches. Most products carry original packaging designed for both stability and safety. Use that first, only transferring to another container if damage forces your hand.
In my experience, skipping the basics about labeling leads straight to confusion. Always mark containers with the date of purchase and opening. It’s easy, and it saves time hunting through supplies or trying to recall when that last shipment came in. Mixing up old and new stock weakens treatments, invites waste, and ruins trust. I keep a logbook with dates and amounts; in a pinch, a notepad by the door is better than nothing.
Accidental spills happen. Quick action with a broom and dustpan, sealed in a heavy-duty bag, protects hands and groundwater alike. Avoiding drains and toilets is essential—these chemicals travel farther in water than anyone wants. Safe storage keeps hands, wildlife, and pets away from danger. No one wants to explain a sick animal just because a lid didn’t fit tight or a bag was ripped open by rodents.
Scientific resources, like official farm extension offices or reputable veterinary manuals, share proven advice. Seasoned farmers do well to double-check manufacturer instructions on every new batch, since changes happen quietly with batch formulations or packaging. Word spreads fast on what works and what doesn’t; whenever advice conflicts, I trust the people and organizations with the strongest track record and open data.
Rules about storage exist for a reason, but I’ve found that common sense beats paperwork. Making it part of every worker’s initial training, and setting up regular walk-throughs, catches problems early. Record-keeping and visible reminders, like checklists on the storage room door, keep those habits alive even in the busiest seasons.
Good storage seems obvious until a costly mistake happens. Caring for ethopabate today protects animals, people, and land tomorrow. For those putting in long hours in animal health, the best lesson is this: a clean, orderly storage space is worth every bit of effort. Mistakes grow expensive and risky in a hurry. Getting storage right pays off more than most folks realize.
Ethopabate gets used in many poultry farms as an anticoccidial drug. Its main purpose is to fight off coccidiosis, a devastating parasitic disease in chickens. Coccidiosis can wipe out flocks and ruin a farmer’s livelihood, so controlling it is a priority. Still, drugs like ethopabate don’t vanish overnight from the birds' systems, and that leads to an important question: do farmers need to wait before selling eggs or meat from treated chickens?
The withdrawal period is the span between the last use of a drug and the moment animal products can be considered safe for human consumption. Not following the right timing means residues might end up in food. In the case of ethopabate, scientific studies and government guidelines play a crucial role.
For meat birds, most countries set a clear withdrawal period—often at least three to five days after the last treatment. The logic behind this is practical. Chickens process the drug through their systems in that time, and tests show residue levels drop below detection or regulatory limits.
Egg-laying hens are another matter. Ethopabate can linger in the birds’ systems long enough to appear in eggs. That’s why government agencies in regions like the European Union and the United States don’t allow the drug for layers whose eggs go to market. The science backs this up: ethopabate residues have been found in eggs for several days after withdrawal, which risks putting consumers in contact with a pharmaceutical they never intended to eat.
Consumers expect their food to be safe, and no one wants to think about picking up medications along with their morning omelet. I’ve spent enough time in both rural and urban kitchens to know many folks crack eggs without a thought about what the chickens might’ve been treated with. That trust doesn’t come out of nowhere—it gets built on rules and transparency. For meat, clear labeling about withdrawal periods lets both producers and shoppers feel secure. For eggs, bans on certain drugs reflect just how quickly food safety can turn into a public issue.
Sometimes farmers are under pressure to harvest or sell early—especially if they’re worried about cash flow. But skipping the waiting period risks far more than a quick buck; it damages both public health and trust in the food system. Traceability and enforcement can be lacking in some areas, but consumers deserve to know what’s in their food, even if trace amounts seem small.
Governments can do more than just set rules—they can offer education and updates to help farmers stay on track. Clear farming records, quicker residue tests, and fair compensation programs during waiting periods all help keep things above board. On the shelves, demanding reliable tracking for eggs and meat boosts consumer confidence.
Some folks have called for more drug-free or organic approaches. I’ve seen small farms have success with herbal coccidiostats and improved sanitation, but these methods need careful management and sometimes cost more. Supporting this kind of shift takes effort across the whole supply chain, from hatchery to grocery aisle.
Ethopabate does what it promises against coccidiosis, but withdrawal periods still serve a bigger promise: clean, safe food that folks can count on. Science, regulation, and a farmer’s own judgment all work together to keep that promise on every table.
| Names | |
| Preferred IUPAC name | Ethyl 4-acetamido-2-ethoxybenzoate |
| Other names |
Ethopabate sodium Ethyl 4-acetamidobenzoate-3-(p-ethoxyphenylcarbamate) Amproban Ethopabate sodium salt |
| Pronunciation | /ˌiːθəˈpæbeɪt/ |
| Identifiers | |
| CAS Number | 59-06-3 |
| 3D model (JSmol) | `JSmol.loadInline("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAA...")` |
| Beilstein Reference | 1723070 |
| ChEBI | CHEBI:5019 |
| ChEMBL | CHEMBL140448 |
| ChemSpider | 21105356 |
| DrugBank | DB03571 |
| ECHA InfoCard | '100.048.368' |
| EC Number | 248-844-0 |
| Gmelin Reference | 74223 |
| KEGG | C14089 |
| MeSH | D004983 |
| PubChem CID | 5370 |
| RTECS number | KH8580000 |
| UNII | K0X4EZD4CA |
| UN number | 3077 |
| Properties | |
| Chemical formula | C13H15NO4 |
| Molar mass | 352.77 g/mol |
| Appearance | White or almost white powder |
| Odor | Odorless |
| Density | 1.33 g/cm³ |
| Solubility in water | Slightly soluble in water |
| log P | 1.88 |
| Vapor pressure | 4.75E-10 mm Hg at 25°C |
| Acidity (pKa) | 13.38 |
| Basicity (pKb) | 12.02 |
| Magnetic susceptibility (χ) | -77.5×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.652 |
| Dipole moment | 3.85 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 489.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -947.3 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -6458.7 kJ/mol |
| Pharmacology | |
| ATC code | QG13AX06 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. |
| GHS labelling | GHS07, GHS09 |
| Pictograms | health hazard", "exclamation mark", "environment |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P264, P270, P273, P280, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 1-1-0-0 |
| Flash point | 115°C |
| Autoignition temperature | Autoignition temperature: 510°C |
| Lethal dose or concentration | LD50 (oral, rat): 4000 mg/kg |
| LD50 (median dose) | LD50 (median dose): 3,000 mg/kg (rat, oral) |
| NIOSH | AN9025000 |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | 125-250 mg/kg feed |
| Related compounds | |
| Related compounds |
Amprolium Clopidol Diclazuril Robenidine Sulfaquinoxaline |
